- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04638088
Comparison of Radical Prostatectomy Performed by Robot-assisted Laparoscopy or Conventional Laparoscopy or by Laparotomy (EMUPRO)
September 20, 2023 updated by: Elsan
Comparison of Radical Prostatectomy for the Treatment of Prostate Cancer, Performed by Robot-assisted or Standard Laparoscopy or by Laparotomy : a Multicentric Prospective Study.
Minimally invasive surgery has developed widely since the 1980s and has revolutionized the practices of surgeons.
In urology, the development of laparoscopy and then robot-assisted surgery has considerably improved the management of pathologies.
In France, as in all the countries concerned, the spread of robotic surgery has taken place without prior studies validating this new technology, nor organizational rules in terms of quality and access to care.
The report of the Haute Autorité de Santé dated November 2016 underlines the weakness of the methodological quality of studies and meta-analyzes evaluating robot-assisted total prostatectomy compared to other surgical techniques by laparotomy or conventional laparoscopy.
It therefore appears important to evaluate in a large study the interest of this technique in order to help the authorities to decide on the real benefit of this technology and to provide reliable answers to the patients.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Minimally invasive surgery has developed widely since the 1980s and has revolutionized the practices of surgeons.
In urology, the development of laparoscopy and then robot-assisted surgery has considerably improved the management of pathologies.
In France, as in all the countries concerned, the spread of robotic surgery has taken place without prior studies validating this new technology, nor organizational rules in terms of quality and access to care.
The report of the Haute Autorité de Santé dated November 2016 underlines the weakness of the methodological quality of studies and meta-analyzes evaluating robot-assisted total prostatectomy compared to other surgical techniques by laparotomy or conventional laparoscopy.
It therefore appears important to evaluate in a large study the interest of this technique in order to help the authorities to decide on the real benefit of this technology and to provide reliable answers to the patients.
Study Type
Observational
Enrollment (Estimated)
2000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Shahnaz KLOUCHE, MD
- Phone Number: 00331 58 56 41 71
- Email: klouche@elsan.care
Study Locations
-
-
-
Agen, France, 47000
- Recruiting
- Clinique Esquirol Saint Hilaire
-
Contact:
- Xavier CUVILLIER, MD
- Phone Number: 00335 53 69 27 15
- Email: xcuvillier@yahoo.fr
-
Principal Investigator:
- Xavier CUVILLIER, MD
-
Avignon, France, 84000
- Completed
- Clinique Rhône Durance
-
Beaumont, France, 63110
- Completed
- Hôpital Privé La Châtaigneraie
-
Besançon, France, 25000
- Recruiting
- Polyclinique de Franche Comté
-
Contact:
- PALMERO Xavier, MD
- Email: xavierpalmero@hotmail.com
-
Principal Investigator:
- PALMERO Xavier, MD
-
Besançon, France, 25000
- Completed
- Clinique St Vincent
-
Bordeaux, France, 33074
- Completed
- Clinique de Saint Augustin
-
Brest, France, 29200
- Recruiting
- Clinique Keraudren - CHPB
-
Contact:
- Maxime THOULOUZAN, MD
- Phone Number: 00332 98 34 29 42
- Email: maxime.thoulouzan@keraudren-grandlarge.fr
-
Principal Investigator:
- Maxime THOULOUZAN, MD
-
Brive-la-Gaillarde, France, 19100
- Recruiting
- Centre Médico-Chirurgical Les Cèdres
-
Contact:
- Pascal BOURNEL, MD
- Email: pascal.bournel@sfr.fr
-
Principal Investigator:
- Pascal BOURNEL, MD
-
Cabestany, France, 6633
- Completed
- Polyclinique Médipôle Saint-Roch
-
Caen, France, 14000
- Recruiting
- Polyclinique du Parc
-
Contact:
- Jean-Georges GUERIN WALLNER, MD
- Email: jeangeorgesgw@gmail.com
-
Principal Investigator:
- Jean-Georges GUERIN WALLNER, MD
-
Carcassonne, France, 11000
- Recruiting
- Polyclinique Montréal
-
Contact:
- Frédéric VAVDIN, MD
- Email: urovavdin@gmail.com
-
Principal Investigator:
- Frédéric VAVDIN, MD
-
Clermont-Ferrand, France, 63100
- Recruiting
- Pôle Santé République
-
Contact:
- Arnaud SCHOENIG, MD
- Phone Number: 00334 73 99 49 49
- Email: arnaud.schoenig@gmail.com
-
Principal Investigator:
- Arnaud SCHOENIG, MD
-
Desertines, France, 03630
- Not yet recruiting
- Hôpital Privé Saint-François
-
Contact:
- Olivier BERDUGO, MD
- Email: o.berdugo@yahoo.fr
-
Principal Investigator:
- Olivier BERDUGO, MD
-
La Seyne-sur-Mer, France, 83500
- Recruiting
- Clinique Cap-d'Or
-
Contact:
- Christophe LEGON, MD
- Email: christolegon@hotmail.fr
-
Principal Investigator:
- Christophe LEGON, MD
-
Le Mans, France, 72000
- Recruiting
- Pôle Santé Sud
-
Contact:
- Olivier BELAS, MD
- Phone Number: 00332 43 78 38 38
- Email: obelas@albarran.fr
-
Principal Investigator:
- Olivier BELAS, MD
-
Limoges, France, 87000
- Recruiting
- Polyclinique de Limoges
-
Contact:
- Franck SALOME, MD
- Phone Number: 00335 55 45 44 05
-
Principal Investigator:
- Franck SALOME, MD
-
Limoges, France, 87000
- Recruiting
- Clinique Emailleurs-Colombier
-
Contact:
- Nicolas LESAUX, MD
- Email: nicolas.lesaux@orange.fr
-
Principal Investigator:
- Nicolas LESAUX, MD
-
Metz, France, 57070
- Not yet recruiting
- Clinique Claude Bernard
-
Contact:
- Bogdan SERBANESCU, MD
- Phone Number: 00333 87 39 69 49
- Email: bgdnserbanescu@gmail.com
-
Principal Investigator:
- Bogdan SERBANESCU, MD
-
Nancy, France, 54100
- Recruiting
- Polyclinique de Gentilly
-
Contact:
- Nicolas HUBERT, MD
- Phone Number: 00333 83 93 50 00
- Email: n.hubert@urolor.fr
-
Principal Investigator:
- Nicolas HUBERT, MD
-
Nantes, France, 44000
- Recruiting
- Clinique Saint-Augustin
-
Contact:
- Quentin Come LE CLERC, MD
- Phone Number: 003302 40 12 30 00
- Email: quentin.come@hotmail.fr
-
Principal Investigator:
- Quentin Come LE CLERC, MD
-
Nîmes, France, 30900
- Completed
- Polyclinique Grand Sud
-
Ollioules, France, 83190
- Completed
- Polyclinique Les Fleurs
-
Poitiers, France, 86000
- Recruiting
- Polyclinique de Poitiers
-
Contact:
- Christian PEYRET, MD
- Email: christian.peyret@orange.fr
-
Principal Investigator:
- Christian PEYRET, MD
-
Roanne, France, 42300
- Not yet recruiting
- Clinique du Renaison
-
Contact:
- Thierry BETHMONT, MD
- Email: thierrybethmont@wanadoo.fr
-
Principal Investigator:
- Thierry BETHMONT, MD
-
Saint-Doulchard, France, 18230
- Recruiting
- Clinique Guillaume De Varye
-
Contact:
- Florent MAILLARD, MD
- Phone Number: 00332 48 68 84 84
- Email: fmaillard59@gmail.com
-
Principal Investigator:
- Florent MAILLARD, MD
-
Soyaux, France, 16800
- Recruiting
- Centre Clinical
-
Contact:
- Serge Gabriele, MD
- Phone Number: 00335 45 97 88 00
- Email: sgabriele@centre-clinical.fr
-
Principal Investigator:
- Serge Gabriele, md
-
Stains, France, 93240
- Completed
- Clinique de l'Estrée
-
Toulouse, France, 31082
- Not yet recruiting
- Clinique Ambroise Pare
-
Contact:
- Frédéric JONCA, MD
- Email: frederic.jonca@numericable.fr
-
Principal Investigator:
- Frédéric JONCA, MD
-
Valenciennes, France, 59300
- Recruiting
- Polyclinique Vauban
-
Contact:
- Tawfik WAHIDY, MD
- Email: tawfik.wahidy@sfr.fr
-
Principal Investigator:
- Tawfik WAHIDY, MD
-
Vannes, France, 56000
- Completed
- Hôpital Privé Océane
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
patient hospitalized for a planned radical prostactectomy .
Description
Inclusion Criteria:
- patient hospitalized for a planned radical prostatectomy
Exclusion Criteria:
- Consent refusal from the patient
- Patients protected by law (Art.L 1121-5, 1121-6, 1121-8 du Code de la santé publique)
- Absence of a French Health Care Insurance coverage
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
robot-assisted laparoscopy
radical prostatectomy performed by robot-assisted laparoscopy
|
assessment of urinary function and erectil function before and after prostatectomy performed by robot assisted or conventional laparoscopy or laparotomy will complete
|
conventional laparoscopy
radical prostatectomy performed by conventional laparoscopy
|
assessment of urinary function and erectil function before and after prostatectomy performed by robot assisted or conventional laparoscopy or laparotomy will complete
|
laparotomy
radical prostatectomy performed by laparotomy
|
assessment of urinary function and erectil function before and after prostatectomy performed by robot assisted or conventional laparoscopy or laparotomy will complete
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Impact of the prostatectomy procedure (robot assisted laparoscopy, conventional laparoscopy and surgical laparotomy) on the urinary function assessed by the EPIC 50 score
Time Frame: 45 Days after the surgery
|
Comparison of the prostatectomy performed by robot assisted laparoscopy or conventional laparoscopy and by surgical laparotomy on the urinary function assessed by the EPIC 50 score (Expanded Prostate Cancer Index Composite)
|
45 Days after the surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
impact of the robot assisted laparoscopy compared to conventional laparoscopy and by surgical laparotomy in radical prostatectomy on the erectile function assessed by the EPIC 50 score
Time Frame: 45 Days after the surgery
|
impact of the robot assisted laparoscopy compared to conventional laparoscopy and by surgical laparotomy on the erectile function assessed by he EPIC 50 score (Expanded Prostate Cancer Index Composite)
|
45 Days after the surgery
|
impact of the robot assisted laparoscopy in prostatectomy on the urinary function assessed by EPIC 50 SCORE
Time Frame: up to 5 years after surgery
|
up to 5 years after surgery
|
|
impact of the robot assisted laparoscopy in prostatectomy on the erectile function assessed by the International Index of Erectile Function (IIEF-5) score
Time Frame: upt to 5 years after the surgery
|
upt to 5 years after the surgery
|
|
Assessment of the cost effectiveness of the robot assisted procedure in prostatectomy assessed by EQ5d-5L score
Time Frame: 12 months
|
Assessment of the cost effectiveness of the robot assisted procedure in prostatectomy assessed by EQ5d-5L score
|
12 months
|
Occurence of prostatectomy sequelae (urinary incontinence or erectile dysfunction )
Time Frame: 3 years
|
3 years
|
|
Occurence of prostatectomy sequelae (urinary incontinence or erectil dysfunction )
Time Frame: 5 years
|
5 years
|
|
Prostate Specific Antigen (PSA) level
Time Frame: up to 5 years
|
measures of the level of PSA in a man's blood
|
up to 5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Shahnaz KLOUCHE, MD, Elsan
- Principal Investigator: Pierre-Thierry PIECHAUD, MD, Elsan
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2021
Primary Completion (Estimated)
March 25, 2024
Study Completion (Estimated)
March 1, 2029
Study Registration Dates
First Submitted
November 16, 2020
First Submitted That Met QC Criteria
November 16, 2020
First Posted (Actual)
November 20, 2020
Study Record Updates
Last Update Posted (Actual)
September 21, 2023
Last Update Submitted That Met QC Criteria
September 20, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GCS-ELSAN-0620
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostate Cancer
-
Roswell Park Cancer InstituteRecruitingObesity | Overweight | Cancer Survivor | Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage A Prostate Cancer | Stage... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Regeneron Pharmaceuticals; Prostate Cancer FoundationWithdrawnStage III Prostate Cancer | Stage IV Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage IIIA Prostate Cancer | Stage IIIB Prostate Cancer | Stage IIIC Prostate Cancer
-
University of Southern CaliforniaNational Cancer Institute (NCI); SanofiTerminatedDiarrhea | Recurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Ryan Kohlbrenner, MDRadiological Society of North AmericaCompletedProstate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Prostate Carcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage...United States
-
Jonsson Comprehensive Cancer CenterProgenics Pharmaceuticals, Inc.TerminatedRandomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer (PSMA-dRT)Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Stage I Prostate...United States
-
Ohio State University Comprehensive Cancer CenterRiverside Methodist HospitalCompletedStage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University of California, IrvineCompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer... and other conditionsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate...United States
Clinical Trials on assessment of urinary function and erectil function before and after prostatectomy
-
Umeå UniversityKarolinska InstitutetCompletedPostoperative Complications | Abdominal Surgery | Lung FunctionSweden
-
RWTH Aachen UniversityHeinrich-Heine University, DuesseldorfCompletedHemodialysisGermany
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaActive, not recruiting
-
Hospices Civils de LyonRecruiting
-
Cairo UniversityCompleted
-
University Hospitals Bristol and Weston NHS Foundation...CompletedType 1 DiabetesUnited Kingdom
-
Umraniye Education and Research HospitalCompletedAnxiety Disorders | Fibromyalgia | DysphoniaTurkey
-
KU LeuvenUniversitaire Ziekenhuizen KU Leuven; Vrije Universiteit BrusselRecruiting
-
Rambam Health Care CampusCompletedSmoking Cessation | Muscle Weakness | Body Composition, BeneficialIsrael
-
HabibedurduCompletedIdiopathic Pulmonary Fibrosis | Interstitial Lung Disease | Sarcoidosis, Pulmonary | GeriatricTurkey